Midodrine Tillomed (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrine Tillomed, is an Alpha-1 adrenergic agonist presented as a tablet for oral use. It raises blood pressure by inducing peripheral vasoconstriction and is indicated for the treatment of orthostatic hypotension in adult patients.

GNH USA supplies Midodrine Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. We support global logistics and offer flexible packaging options to meet diverse market requirements.

Midodrine acts on the peripheral vascular system to counteract low blood pressure associated with orthostatic disorders.

- Orthostatic hypotension: Improves standing blood pressure and reduces dizziness or fainting episodes. - Neurogenic orthostatic hypotension: Increases vascular tone in patients with autonomic failure, enhancing orthostatic tolerance. - Symptomatic hypotension: Elevates blood pressure in conditions such as chronic fatigue or post‑ural hypotension, providing symptomatic relief.

Midodrine may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Piloerection (goose‑flesh skin) - Pruritus (itching) - Urinary retention - Supine hypertension - Headache - Nausea

Serious or Rare Side Effects: - Severe hypertension, especially when lying down - Cardiac arrhythmias or myocardial infarction - Angina pectoris - Anaphylactic or severe allergic reactions - Peripheral ischemia

When prescribing Midodrine, clinicians should observe several safety measures.

- Blood pressure monitoring: Check supine and standing pressures regularly. - Supine hypertension risk: Avoid lying flat for several hours after dosing. - Cardiovascular disease caution: Use carefully in patients with ischemic heart disease. - Renal impairment adjustment: Dose may need modification in severe renal dysfunction. - Contraindications: Do not use in patients with severe organic heart disease or pheochromocytoma. - Store at ambient temperature: Keep tablets in the original container, protect from moisture and light.

Midodrine can interact with other medications that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Other alpha‑adrenergic agonists (e.g., phenylephrine) – additive hypertensive effect. - Monoamine oxidase inhibitors – risk of excessive vasoconstriction. - Direct vasopressors (e.g., norepinephrine) – may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Diuretics – may amplify blood pressure changes. - ACE inhibitors or ARBs – potential for unpredictable blood pressure response. - Beta‑blockers – may mask tachycardia associated with hypertension. - Anticholinergic agents – increased risk of urinary retention. - Non‑steroidal anti‑inflammatory drugs – may affect renal handling of the drug.